MAPT and mild neurocognitive disorder: Within the FTD subtypes, there was a tendency for groups with probable TDP-43 pathology (svPPA and FTD-MND clinically, GRN and C9orf72 mutations genetically) to have raised levels compared with those associated with tau pathology (MAPT mutations), although within all groups there is substantial variability.